Efficacy of mosapride citrate with polyethylene glycol solution for colonoscopy preparation

World Journal of Gastroenterology

Volumn 18, Issue 20, 2012, Pages 2517-2525

  Tajika, Masahiro ^a   Niwa, Yasumasa ^a   Bhatia, Vikram ^b   Kawai, Hiroki ^a   Kondo, Shinya ^a   Sawaki, Akira ^a   Mizuno, Nobumasa ^a   Hara, Kazuo ^a   Hijioka, Susumu ^a   Matsumoto, Kazuya ^a   Kobayashi, Yuji ^a   Saeki, Akira ^a   Akabane, Asana ^a   Komori, Koji ^a   Yamao, Kenji ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

Author keywords

Bowel preparation; Colonoscopy; Mosapride citrate; Polyethylene glycol electrolyte solution; Prokinetics

Indexed keywords

MACROGOL; MOSAPRIDE; PLACEBO; BENZAMIDE DERIVATIVE; LAXATIVE; MACROGOL DERIVATIVE; MORPHOLINE DERIVATIVE; SEROTONIN AGONIST;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADULT; ADVERSE DRUG REACTION; AGED; ARONCHICK CRITERIA; ARTICLE; COLON DILATATION; COLONOSCOPY; CONTROLLED STUDY; DISEASE ASSESSMENT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; FEMALE; HUMAN; INCIDENCE; INTESTINE PREPARATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NAUSEA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VOMITING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METHODOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRE;

AGED; BENZAMIDES; CATHARTICS; COLONOSCOPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; PATIENT COMPLIANCE; POLYETHYLENE GLYCOLS; QUESTIONNAIRES; SEROTONIN RECEPTOR AGONISTS;

EID: 84871872700     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i20.2517     Document Type: Article

References (40)

1. Iida Y, Miura S, Asada Y, Fukuoka K, Toya D, Tanaka N, Fujisawa M. Bowel preparation for the total colonoscopy by 2,000 ml of balanced lavage solution (Golytely) and sennoside. Gastroenterol Jpn 1992; 27: 728-733
2. Harewood GC, Wiersema MJ, Melton LJ. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002; 97: 3186-3194
3. Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, Nowacki MP, Butruk E. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355: 1863-1872
4. Wexner SD, Beck DE, Baron TH, Fanelli RD, Hyman N, Shen B, Wasco KE. A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc 2006; 63: 894-909
5. Ness RM, Manam R, Hoen H, Chalasani N. Predictors of inadequate bowel preparation for colonoscopy. Am J Gastroenterol 2001; 96: 1797-1802
6. Ziegenhagen DJ, Zehnter E, Tacke W, Gheorghiu T, Kruis W. Senna vs. bisacodyl in addition to Golytely lavage for colonoscopy preparation - a prospective randomized trial. Z Gastroenterol 1992; 30: 17-19
7. Lazarczyk DA, Stein AD, Courval JM, Desai D. Controlled study of cisapride-assisted lavage preparatory to colonoscopy. Gastrointest Endosc 1998; 48: 44-48
8. Reiser JR, Rosman AS, Rajendran SK, Berner JS, Korsten MA. The effects of cisapride on the quality and tolerance of colonic lavage: a double-blind randomized study. Gastrointest Endosc 1995; 41: 481-484
9. Katsinelos P, Pilpilidis I, Paroutoglou G, Xiarchos P, Tsolkas P, Papagiannis A, Giouleme O, Kapelidis P, Papageorgiou A, Dimiropoulos S, Eugenidis N. The administration of cisapride as an adjuvant to PEG-electrolyte solution for colonic cleansing: a double-blind randomized study. Hepatogastroenterology 2005; 52: 441-443
10. Martínek J, Hess J, Delarive J, Jornod P, Blum A, Pantoflickova D, Fischer M, Dorta G. Cisapride does not improve precolonoscopy bowel preparation with either sodium phosphate or polyethylene glycol electrolyte lavage. Gastrointest Endosc 2001; 54: 180-185
11. Brady CE, DiPalma JA, Pierson WP. Golytely lavage - is metoclopramide necessary? Am J Gastroenterol 1985; 80: 180-184
12. Rhodes JB, Engstrom J, Stone KF. Metoclopramide reduces the distress associated with colon cleansing by an oral electrolyte overload. Gastrointest Endosc 1978; 24: 162-163
13. Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 1982; 24: 360-400
14. Tonini M, De Ponti F, Di Nucci A, Crema F. Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 1999; 13: 1585-1591
15. Yoshida N, Omoya H, Oka M, Furukawa K, Ito T, Karasawa T. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Arch Int Pharmacodyn Ther 1989; 300: 51-67
16. Ruth M, Finizia C, Cange L, Lundell L. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2003; 15: 1115-1121
17. Mizuta Y, Shikuwa S, Isomoto H, Mishima R, Akazawa Y, Masuda J, Omagari K, Takeshima F, Kohno S. Recent insights into digestive motility in functional dyspepsia. J Gastroenterol 2006; 41: 1025-1040
18. Asakawa H, Hayashi I, Fukui T, Tokunaga K. Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy. Diabetes Res Clin Pract 2003; 61: 175-182
19. McLean PG, Coupar IM. Stimulation of cyclic AMP formation in the circular smooth muscle of human colon by activation of 5-HT4-like receptors. Br J Pharmacol 1996; 117: 238-239
20. Sakurai-Yamashita Y, Yamashita K, Kanematsu T, Taniyama K. Localization of the 5-HT(4) receptor in the human and the guinea pig colon. Eur J Pharmacol 1999; 383: 281-285
21. Nagashima M, Okamura S, Iizuka H, Ohmae Y, Sagawa T, Kudo T, Masuo T, Kobayashi R, Marubashi K, Ishikawa T, Oshimoto H, Yoshida M, Motegi K, Sakamoto T, Iesaki K, Mori M. Mosapride citrate for colonoscopy preparation with lavage. Kitakanto Med J 2002; 52: 111-115
22. Mishima Y, Amano Y, Okita K, Takahashi Y, Moriyama N, Ishimura N, Furuta K, Ishihara S, Adachi K, Kinoshita Y. Efficacy of prokinetic agents in improving bowel preparation for colonoscopy. Digestion 2008; 77: 166-172
23. Sakashita M, Yamaguchi T, Miyazaki H, Sekine Y, Nomiyama T, Tanaka S, Miwa T, Harasawa S. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects. Arzneimittelforschung 1993; 43: 867-872
24. Aronchick CA, Lipshutz WH, Wright SH, Dufrayne F, Bergman G. A novel tableted purgative for colonoscopic preparation: efficacy and safety comparisons with Colyte and Fleet Phospho-Soda. Gastrointest Endosc 2000; 52: 346-352
25. Hunt RH, Tougas G. Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments. Best Pract Res Clin Gastroenterol 2002; 16: 869-883
26. Yoshida N, Kato S, Ito T. Mosapride Citrate. Drugs Future 1993; 18: 513-515
27. Hongo M. Initial approach and pharmacotherapy for functional dyspepsia - a large clinical trial in Japan. Gastroenterology 2006; 130: A-506
28. Kanaizumi T, Nakano H, Matsui Y, Ishikawa H, Shimizu R, Park S, Kuriya N. Prokinetic effect of AS-4370 on gastric emptying in healthy adults. Eur J Clin Pharmacol 1991; 41: 335-337
29. Inui A, Yoshikawa T, Nagai R, Yoshida N, Ito T. Effects of mosapride citrate, a 5-HT4 receptor agonist, on colonic motility in conscious guinea pigs. Jpn J Pharmacol 2002; 90: 313-320
30. Jost WH, Schimrigk K. Long-term results with cisapride in Parkinson's disease. Mov Disord 1997; 12: 423-425
31. Kii Y, Nakatsuji K, Nose I, Yabuuchi M, Mizuki Y, Ito T. Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats. Pharmacol Toxicol 2001; 89: 96-103
32. Taniyama K, Makimoto N, Furuichi A, Sakurai-Yamashita Y, Nagase Y, Kaibara M, Kanematsu T. Functions of peripheral 5-hydroxytryptamine receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. J Gastroenterol 2000; 35: 575-582
33. Odaka T, Suzuki T, Seza A, Yamaguchi T, Saisho H. [Serotonin 5-HT4 receptor agonist (mosapride citrate)]. Nihon Rinsho 2006; 64: 1491-1494
34. Liu Z, Sakakibara R, Odaka T, Uchiyama T, Uchiyama T, Yamamoto T, Ito T, Asahina M, Yamaguchi K, Yamaguchi T, Hattori T. Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients. Mov Disord 2005; 20: 680-686
35. Shimatani H, Kojima Y, Kadowaki M, Nakagawa T, Fujii H, Nakajima Y, Takaki M. A 5-HT4 agonist mosapride enhances rectorectal and rectoanal reflexes in guinea pigs. Am J Physiol Gastrointest Liver Physiol 2003; 285: G389-G395
36. Mine Y, Morikage K, Oku S, Yoshikawa T, Shimizu I, Yoshida N. Effect of mosapride citrate hydrate on the colon cleansing action of polyethylene glycol electrolyte lavage solution (PEG-ELS) in guinea pigs. J Pharmacol Sci 2009; 110: 415-423
37. Kim HS, Choi EJ, Park H. The effect of mosapride citrate on proximal and distal colonic motor function in the guinea-pig in vitro. Neurogastroenterol Motil 2008; 20: 169-176
38. Oikawa T, Takemoto Y, Haramu K. Post-marketing surveillance of mosapride citrate (Gasmotin) in patients with nonulcer dyspepsia on long-term administration [in Japanese]. Rinsho Iyaku 2005; 21: 831-837
39. Futei S, Sugino Y, Kuribayashi S, Imai Y, Ueno F, Hibi T, Mitsushima T. [New preparation method for barium enema: efficacy and administration of oral intestinal lavage solution with gastrointestinal prokinetic agent]. Nihon Igaku Hoshasen Gakkai Zasshi 2004; 64: 22-30
40. Miyoshi A, Miwa T, Harasawa S, Yoshida Y, Masamune O, Kimura K, Niwa H, Mori H, Asakura H, Hayakawa T, Kamata T, Kajiyama G, Hayakawa A, Nakashima M. Dosefinding study of AS-4370 (mosapride citrate) in patients with chronic gastritis [in Japanese]. Rinsho Iyaku 1998; 14: 1069-1090